Beata Sieklucka
Overview
Explore the profile of Beata Sieklucka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Plonski A, Krupa A, Pawlak D, Sokolowska K, Sieklucka B, Gabriel M, et al.
Pharmacol Rep
. 2025 Mar;
PMID: 40063220
Background: The understanding of endothelin's role in carotid plaque instability is limited. We have studied the big endothelin-1 (ET-1) axis and its role in carotid plaque stability in patients undergoing...
2.
Nowowiejska J, Baran A, Pryczynicz A, Hermanowicz J, Sieklucka B, Pawlak D, et al.
Dermatol Pract Concept
. 2024 Aug;
14(3).
PMID: 39122519
Introduction: Psoriasis is a frequent and incurable skin disease that is an important issue in contemporary dermatology, although its pathogenesis is still uncertain. Gasdermin A (GSDMA) is a member of...
3.
Nowowiejska J, Baran A, Pryczynicz A, Hermanowicz J, Sieklucka B, Pawlak D, et al.
Front Mol Biosci
. 2024 May;
11:1382069.
PMID: 38693919
Psoriasis is one of the most common skin diseases and a crucial issue to manage in contemporary dermatology. The search for the details of its pathogenesis, markers and treatment is...
4.
Kopanko M, Zabludowska M, Pawlak D, Sieklucka B, Krupa A, Sokolowska K, et al.
J Clin Med
. 2024 Apr;
13(7).
PMID: 38610612
: The purpose of the study was to determine whether the use of β-adrenoceptor antagonists (β-blockers) can affect metalloproteinase 2 (MMP-2) and its tissue inhibitor (TIMP-2) in patients with chronic...
5.
Karbowska M, Pawlak K, Sieklucka B, Domaniewski T, Lebkowska U, Zawadzki R, et al.
Sci Rep
. 2024 Jan;
14(1):2583.
PMID: 38297036
Indoxyl sulfate (IS), an agonist of aryl hydrocarbon receptors (AhR), can accumulate in patients with chronic kidney disease, but its direct effect on bone is not clear. The present study...
6.
Nowowiejska J, Baran A, Hermanowicz J, Sieklucka B, Pawlak D, Flisiak I
Biomolecules
. 2023 Oct;
13(10).
PMID: 37892153
Psoriasis is a complex disease that nowadays is considered not only a dermatosis but a kind of systemic disorder associated with many accompanying diseases. Metabolic complications leading to cardiovascular incidences...
7.
Nowowiejska J, Baran A, Hermanowicz J, Pryczynicz A, Sieklucka B, Pawlak D, et al.
Int J Mol Sci
. 2023 Sep;
24(17).
PMID: 37685853
Psoriasis is an important issue in daily dermatological practice. Not only is it an aesthetic defect but it is also a matter of decreased life quality and economic burden. However...
8.
Nowowiejska J, Baran A, Pryczynicz A, Hermanowicz J, Sieklucka B, Pawlak D, et al.
Cells
. 2023 Sep;
12(17).
PMID: 37681881
Psoriasis is a frequent and incurable skin disease whose pathogenesis is still not fully understood. It is characterized by immune disturbances leading to hyperproliferation and improper differentiation of keratinocytes. Gasdermin...
9.
Nowowiejska J, Baran A, Hermanowicz J, Sieklucka B, Pawlak D, Flisiak I
Dermatol Ther (Heidelb)
. 2023 Aug;
13(10):2217-2227.
PMID: 37568012
Introduction: Psoriasis, one of the most frequent dermatoses, strongly associated with metabolic disorders which increase patients' comorbidity and mortality. Hence, it is essential to look for markers of such complications....
10.
Zieminska M, Pawlak D, Sieklucka B, Chilkiewicz K, Pawlak K
Nutrients
. 2022 Oct;
14(19).
PMID: 36235734
Chronic kidney disease (CKD) commonly occurs with vitamin K (VK) deficiency and impaired bone mineralization. However, there are no data explaining the metabolism of endogenous VK and its role in...